Genome-wide association studies in pharmacogenomics

被引：0
作者：
Ann K. Daly
机构：
[1] Ann K. Daly is at the Institute of Cellular Medicine,
[2] Newcastle University,undefined
[3] Newcastle upon Tyne NE2 4HH,undefined
[4] UK. a.k.daly@ncl.ac.uk,undefined
来源：
Nature Reviews Genetics | 2010年 / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The use of genome-wide association (GWA) approaches to identify variants that affect drug response or reaction is increasing rapidly, with at least 12 studies appearing in 2009 alone. This article reviews these pharmacogenomics GWA studies, and the prospects for this field.
引用
收藏
页码：241 / 246
页数：5
相关论文
共 73 条
  • [21] Seeringer A(2009), and Lancet 373 309-586
  • [22] Kirchheiner J(2009) and hypersensitivity to HIV-1 reverse transcriptase inhibitor abacavir JAMA 302 1429-757
  • [23] Kirchheiner J(2009) screening for hypersensitivity to abacavir Nature Rev. Cancer 9 576-581
  • [24] Hulot JS(2006)Pharmacogenetics-guided dose modifications of antidepressants Ann. Intern. Med. 145 749-819
  • [25] Simon T(2008) and Mol. Med. 14 575-4112
  • [26] Collet JP(2009) genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages Mol. Psychiatry 14 804-789
  • [27] Schroth W(2008)Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects Blood 111 4106-266
  • [28] Hoskins JM(2009)Genetic determinants of response to clopidogrel and cardiovascular events Pharmacogenet. Genomics 19 781-1290
  • [29] Carey LA(2009)Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study Pharmacogenomics 10 261-15422
  • [30] McLeod HL(2000)Association between Drug Metab. Dispos. 28 1284-358
12345678